| |
| |
|
| Insider
Information: |
Kennedy Giulia C |
| Relationship: |
Chief Scientific & Med... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
65,970 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,509,394 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
65,970 |
|
|
| Total
Value |
$1,509,394 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Veracyte, Inc. |
VCYT |
Chief Scientific & Med... |
2022-12-06 |
65,970 |
2019-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,400 |
|
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-11-11 |
4 |
AS |
$29.34 |
$59 |
D/D |
(2) |
68,001 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-11-11 |
4 |
OE |
$14.34 |
$29 |
D/D |
2 |
68,003 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-08-05 |
4 |
OE |
$5.43 |
$39 |
D/D |
5 |
71,060 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-11-01 |
4 |
D |
$51.80 |
$7,718 |
D/D |
(149) |
49,900 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-06-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(292) |
48,332 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-09-03 |
4 |
D |
$25.09 |
$7,326 |
D/D |
(292) |
47,745 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-12-02 |
4 |
D |
$27.19 |
$7,939 |
D/D |
(292) |
47,157 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-09-04 |
4 |
AS |
$25.20 |
$7,458 |
D/D |
(296) |
47,449 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
81,574 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2020-06-02 |
4 |
D |
$26.01 |
$14,045 |
D/D |
(540) |
81,034 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• • – |
2020-09-02 |
4 |
D |
$34.16 |
$18,446 |
D/D |
(540) |
79,947 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• • – |
2020-12-02 |
4 |
D |
$55.08 |
$29,743 |
D/D |
(540) |
78,859 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(813) |
48,587 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2020-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(896) |
99,122 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-06-02 |
4 |
D |
$36.07 |
$32,896 |
D/D |
(912) |
52,812 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-09-02 |
4 |
D |
$52.97 |
$48,309 |
D/D |
(912) |
50,975 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-12-02 |
4 |
D |
$39.22 |
$35,769 |
D/D |
(912) |
48,988 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-09-08 |
4 |
AS |
$50.53 |
$46,791 |
D/D |
(926) |
50,049 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-06-02 |
4 |
D |
$18.23 |
$18,376 |
D/D |
(1,008) |
60,353 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-09-02 |
4 |
D |
$19.18 |
$19,333 |
D/D |
(1,008) |
69,024 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-12-02 |
4 |
D |
$29.14 |
$29,373 |
D/D |
(1,008) |
66,993 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-11-04 |
4 |
AS |
$25.00 |
$25,575 |
D/D |
(1,023) |
68,001 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-12-06 |
4 |
AS |
$27.03 |
$27,652 |
D/D |
(1,023) |
65,970 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-08-05 |
4 |
AS |
$26.54 |
$27,283 |
D/D |
(1,028) |
70,032 |
0 |
% |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
